TrailBlazer Updates LCD for Chemo Drugs

  • By
  • In Coding
  • June 29, 2009
  • Comments Off on TrailBlazer Updates LCD for Chemo Drugs

Medicare Administrative Contractor (MAC) TrailBlazer recently announced an inadvertent coding error. ICD-9-CM diagnosis code 238.79 Other lymphatic and hematopoietic tissues, used to indicate B-cell lymphoproliferative disorders expressing the CD-20 antigen as a covered diagnosis for J9310 Injection, rituximab, 100 mg, should be replaced with ICD-9-CM diagnosis code 238.77 Post-Transplant Lymphoproliferative Disorder (PTLD).

TrailBlazer has made this change in the most recent version of each Local Coverage Determination (LCD) listed below:

For jurisdiction 4 (J4) (Colorado, New Mexico, Oklahoma, and Texas):

Drugs and Biologicals – Chemotherapeutic – 4I-92AB

For Part B Virginia:

Drugs and Biologicals – Chemotherapeutic Drugs J9000–J9999 – I-68B

This change is effective with claims submitted on or after July 17 for dates of service on or after Oct. 1, 2008.

Latest posts by admin aapc (see all)

Comments are closed.